References
- Nortvedt MW, Riise T, Myhr KM, Landtblom AM, Bakke A, Nyland HI. Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Multiple Sclerosis7, 231–235 (2001).
- Nortvedt M, Riise T, Myhr KM. Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology53, 1098–1103 (1999).
- Pommerville P. Erectile dysfunction: an overview. Can. J. Urol.89(Suppl. 1), 2–6 (2003).
- Lilius HG, Valltonen EJ, Wikström J. Sexual problems in patients suffering from multiple sclerosis. Scand. J. Soc. Med.4, 41–44 (1976).
- Lundberg PO. Sexual dysfunction of patients with multiple sclerosis. Sex Disabil.1, 218–233 (1978).
- Lundberg PO, Brattberg A. Sexual dysfunction in selected neurological disorders, epilepsy, myelopathies, polyneuropathies and sacral nerve lesions. Semin. Neurol.12, 115–119 (1992).
- Ghezzi A. Sexual dysfunction in multiple sclerosis. Int. MS J.2, 45–53 (1999).
- Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J. Neurol. Sci.1, 51–58 (2002).
- Piediferro G, Colpi EM, Castiglioni F, Nerva F. Premature ejaculation. 1. Definition and etiology. Arch. Ital. Urol. Androl.76(4), 181–187 (2004).
- Witt MA, Grantmyre JE. Ejaculatory failure. World J. Urol.11(2), 89–95 (1993).
- Denys P, Mane M, Azouvi P, Chartier-Kastler E, Thiebaut JB, Bussel B. Side effects of chronic intrathecal baclofen on erection and ejaculation in patients with spinal cord lesions. Arch. Phys. Med. Rehab.79(5), 494–496 (1998).
- Urciuoli R, Cantisani TA, Carlinil M, Giuglietti M, Botti FM. Prostaglandin E1 for treatment of erectile dysfunction. Cochrane Database Syst. Rev.2, CD001784 (2004).
- Carrier S, Brock GB, Pommerville PJ et al. Efficacy and safety of oral tadalfil in the treatment of men in Canada with erectile dysfunction: a randomised, double-blind, parallel, placebo-controlled clinical trial. J. Sex Med.2(5), 685–698 (2005).
- Fowler CJ, Miller JR, Sharief MK, Hussain IF, Stecher VJ, Sweeney M. A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis. J. Neurol. Neurosurg. Psych.76, 700–705 (2005).
- Masson P, Lambert SM, Brown M, Shabsigh R. PDE-5 inhibitors: current status and future trends. Urol. Clin. North Am.4, 511 (2005).
- DasGupta R, Wiseman OJ, Kanabar G, Fowler CJ. Efficacy of sildenafil in the treatment of female sexual dysfunction due to multiple sclerosis. J. Urol.3, 1189–1193 (2004).
- Pavone C, Curto F, Anello G, Serretta V, Almasio PL, Pavone-Macaluso M. Prospective, randomised, crossover comparison of sublingual apomorphine (3 mg) with oral sildenafil (50 mg) for male erectile dysfunction. J. Urol.172(6 Pt 1), 2347–2349 (2004).
- Perimenis P, Markou S, Gyftopoulos K et al. Efficacy of apomorphine and sildenafil in men with nonarteriogenic erectile dysfunction. A comparative crossover study. Andrologia36(3), 106–110 (2004).
- Foley FW, LaRocca NG, Sanders AS, Zemon V. Rehabilitation of intimacy and sexual dysfunction in couples with multiple sclerosis. Multiple sclerosis7(6), 417–421 (2001).
- Maslow AH. Towards a psychology of being. Van Nostrand Company, NY, USA (1968).